| 11/04/2026 3:07 PM | Agilon Health (1831097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/04/2026 3:09 PM | Agilon Health (1831097) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/18/2026 4:44 PM | Agilon Health (1831097) Issuer Gertsch Timothy (1990304) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2026 6:09 AM | Agilon Health (1831097) Subject AQR CAPITAL MANAGEMENT LLC (1167557) Filed by | Form SCHEDULE 13G/A | |
| 08/11/2026 6:15 PM | Agilon Health (1831097) Subject GOLDMAN SACHS GROUP INC (886982) Filed by | Form SCHEDULE 13G/A | |
| 08/05/2026 3:11 PM | Agilon Health (1831097) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 3:07 PM | Agilon Health (1831097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/02/2026 5:44 PM | Agilon Health (1831097) Issuer Schwaneke Jeffrey A. (1446919) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 6:46 PM | Agilon Health (1831097) Issuer Zamore Denise (2062727) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 8:55 PM | Agilon Health (1831097) Issuer Battaglia Silvana (1774724) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 8:55 PM | Agilon Health (1831097) Issuer Mansukani Sharad (1402190) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AGL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agilon Health and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/04/2026 8:56 PM | Agilon Health (1831097) Issuer MCKENZIE DIANA (1754648) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 8:56 PM | Agilon Health (1831097) Issuer McLoughlin Karen (1541704) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 8:56 PM | Agilon Health (1831097) Issuer WILLIAMS RONALD A (1185243) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 8:57 PM | Agilon Health (1831097) Issuer Wulf John William (1856345) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 3:31 PM | Agilon Health (1831097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 7:08 PM | Agilon Health (1831097) Issuer Gertsch Timothy (1990304) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 11:53 AM | Agilon Health (1831097) Subject AQR CAPITAL MANAGEMENT LLC (1167557) Filed by | Form SCHEDULE 13G | |
| 05/13/2026 9:28 AM | Agilon Health (1831097) Subject GOLDMAN SACHS GROUP INC (886982) Filed by | Form SCHEDULE 13G | |
| 05/11/2026 4:05 PM | Agilon Health (1831097) Issuer O'Rourke Timothy Patrick (2134052) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 4:05 PM | Agilon Health (1831097) Issuer O'Rourke Timothy Patrick (2134052) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/27/2026 3:18 PM | Agilon Health (1831097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 3:21 PM | Agilon Health (1831097) Filer | Form DEFA14A | |
| 04/23/2026 3:42 PM | Agilon Health (1831097) Filer | Form DEFA14A | |
| 04/23/2026 3:43 PM | Agilon Health (1831097) Filer | Form ARS | |
| 04/22/2026 3:49 PM | Agilon Health (1831097) Filer | Form DEF 14A | |
| 04/16/2026 7:08 PM | Agilon Health (1831097) Issuer Gertsch Timothy (1990304) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:09 PM | Agilon Health (1831097) Issuer Venkatachaliah Girish (1855795) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:12 PM | Agilon Health (1831097) Issuer Zamore Denise (2062727) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:06 PM | Agilon Health (1831097) Issuer Shaker Benjamin (1855843) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 6:38 PM | Agilon Health (1831097) Issuer Gertsch Timothy (1990304) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 6:39 PM | Agilon Health (1831097) Issuer Shaker Benjamin (1855843) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 6:40 PM | Agilon Health (1831097) Issuer Schwaneke Jeffrey A. (1446919) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 6:36 PM | Agilon Health (1831097) Issuer Zamore Denise (2062727) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 6:37 PM | Agilon Health (1831097) Issuer Venkatachaliah Girish (1855795) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/11/2026 3:49 PM | Agilon Health (1831097) Issuer Shaker Benjamin (1855843) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/11/2026 3:50 PM | Agilon Health (1831097) Issuer Venkatachaliah Girish (1855795) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/11/2026 3:50 PM | Agilon Health (1831097) Issuer Zamore Denise (2062727) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 6:07 AM | Agilon Health (1831097) Filer | Form PRE 14A | |
| 01/30/2026 6:30 PM | Agilon Health (1831097) Issuer Wulf John William (1856345) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:44 PM | Agilon Health (1831097) Issuer Schwaneke Jeffrey A. (1446919) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Pentagon magnet restrictions take effect January 1, 2027 (Ad) A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production.
The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing.
The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027. Read the full breakdown of the proposed Army rare earth agreement and the company behind it. |
| 01/07/2026 3:10 PM | Agilon Health (1831097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |